These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10201823)

  • 41. Methemoglobin pathophysiology.
    Jaffé ER
    Prog Clin Biol Res; 1981; 51():133-51. PubMed ID: 7022466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The mechanisms of drug resistance in malaria parasites.
    Peters W
    J Parasitol; 1971 Aug; 57(4):103-7. PubMed ID: 5001106
    [No Abstract]   [Full Text] [Related]  

  • 43. The kinetics and inhibition of the enzyme methemoglobin reductase. A biochemistry experiment.
    Splittgerber AG; Mitchell K; Dahle G; Puffer M; Blomquist K
    J Chem Educ; 1975 Oct; 52(10):680-1. PubMed ID: 1194379
    [No Abstract]   [Full Text] [Related]  

  • 44. Expeditious one-pot synthesis of C3-piperazinyl-substituted quinolines: key precursors to potent c-Met inhibitors.
    Wang Y; Ai J; Liu G; Geng M; Zhang A
    Org Biomol Chem; 2011 Sep; 9(17):5930-3. PubMed ID: 21785792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
    Goldring JD; Padayachee T; Ismail I
    Mem Inst Oswaldo Cruz; 1999; 94(5):667-74. PubMed ID: 10464415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine.
    Fasinu PS; Tekwani BL; Avula B; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan IA; Walker LA
    Malar J; 2016 Sep; 15(1):466. PubMed ID: 27618912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The hemolytic effect of primaquine. XV. Role of methemoglobin.
    BREWER GJ; TARLOV AR; KELLERMEYER RW; ALVING AS
    J Lab Clin Med; 1962 Jun; 59():905-17. PubMed ID: 13872969
    [No Abstract]   [Full Text] [Related]  

  • 48. Control of heme polymerase by chloroquine and other quinoline derivatives.
    Chou AC; Fitch CD
    Biochem Biophys Res Commun; 1993 Aug; 195(1):422-7. PubMed ID: 8363618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.
    Ryckebusch A; Deprez-Poulain R; Maes L; Debreu-Fontaine MA; Mouray E; Grellier P; Sergheraert C
    J Med Chem; 2003 Feb; 46(4):542-57. PubMed ID: 12570376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemoselective synthesis and biological evaluation of arylated 2-(Trifluoromethyl) quinolines as nucleotide pyrophosphatase (NPPs) inhibitors.
    Kuhrt D; Ejaz SA; Afzal S; Khan SU; Lecka J; Sévigny J; Ehlers P; Spannenberg A; Iqbal J; Langer P
    Eur J Med Chem; 2017 Sep; 138():816-829. PubMed ID: 28735213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors.
    Kravchenko DV; Kysil VV; Ilyn AP; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1841-5. PubMed ID: 15780618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cryptolepine analogues containing basic aminoalkyl side-chains at C-11: synthesis, antiplasmodial activity, and cytotoxicity.
    Lavrado J; Paulo A; Gut J; Rosenthal PJ; Moreira R
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1378-81. PubMed ID: 18207399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
    Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
    Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergizes with Quinoline-Derived Antimalarials.
    Vallières C; Avery SV
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A primaquine-chloroquine hybrid with dual activity against Plasmodium liver and blood stages.
    Lödige M; Lewis MD; Paulsen ES; Esch HL; Pradel G; Lehmann L; Brun R; Bringmann G; Mueller AK
    Int J Med Microbiol; 2013 Dec; 303(8):539-47. PubMed ID: 23992634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimalarials: effects on in vivo and in vitro protein synthesis.
    Conklin KA; Chou SC
    Science; 1970 Dec; 170(3963):1213-4. PubMed ID: 5478195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of potential antimalarials: primaquine analogs.
    Talati SM; Latham MR; Moore EG; Hargreaves GW; DeWitt Blanton C
    J Pharm Sci; 1970 Apr; 59(4):491-5. PubMed ID: 5440676
    [No Abstract]   [Full Text] [Related]  

  • 58. Computational Study on the Effect of Exocyclic Substituents on the Ionization Potential of Primaquine: Insights into the Design of Primaquine-Based Antimalarial Drugs with Less Methemoglobin Generation.
    Liu H; Ding Y; Walker LA; Doerksen RJ
    Chem Res Toxicol; 2015 Feb; 28(2):169-74. PubMed ID: 25222923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methemoglobin reduction by NADH-cytochrome b(5) reductase in Propsilocerus akamusi larvae.
    Maeda S; Kobori H; Tanigawa M; Sato K; Yubisui T; Hori H; Nagata Y
    Comp Biochem Physiol B Biochem Mol Biol; 2015 Jul; 185():54-61. PubMed ID: 25829149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
    Kravchenko DV; Kuzovkova YA; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Balakin KV; Ivachtchenko AV
    J Med Chem; 2005 Jun; 48(11):3680-3. PubMed ID: 15916416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.